Primary biliary cirrhosis is a chronic autoimmune liver disease, originally thought to be rare and relentlessly progressive to almost invariable death from cirrhosis or complications of portal hypertension.
1,2 Improved methodology of laboratory tests and increased diagnostic activity, together with case series published from many other countries, have shown that the disease may be surprisingly common in some parts of the world and has a very variable disease course. [3] [4] [5] Much of the available 'epidemiological' data on primary biliary cirrhosis is in the form of case series. [3] [4] [5] [6] Epidemiological studies using case-finding methods in defined populations and time periods have reported relatively small numbers of patients, often from large geographical areas. They have limitations in varying case inclusion criteria and completeness of case-finding methods, often due to the availability of information or differences in health care systems. Many studies relied only upon previously diagnosed primary biliary cirrhosis patients in order to identify cases. Since a high proportion of primary biliary cirrhosis patients are asymptomatic or the diagnosis may have been missed, such studies must inevitably lead to a considerable underestimate of true cases in a particular population. However, there is a serological marker, the antimitochondrial antibody (AMA), which is both sensitive (83%) and specific (100%), which is checked as part of an auto-antibody screen for investigation of many diseases. 7, 8 The tracing of all individuals found to be AMA positive within a population thus offers an opportunity by which new cases of primary biliary cirrhosis may be identified in a population and hence come close to 'true' data concerning prevalence. While this method has been used in several studies, its use has often been inconsistent and incomplete due to availability of data, or possible cases have not been systemically followed up and investigated. Table 1 summarises the main published studies and describes the case-finding methods used.
The incidence and prevalence of primary biliary cirrhosis is reportedly very variable between countries but is generally more common in Northern Europe (Table 1) . The three most recent and comparable published epidemiological studies are from north east England, published in 1990 9 and the Swedish studies from Örebro, 1985 10 and Umeä, 1990. 11 These report the highest published prevalence rates in the world of between 92 10 and 151 11 per million population. All three indicated that prevalence was increasing, however the changes in disease incidence were less clear, and slower than the apparent rise in prevalence, which probably reflects increased survival times.
We report the results of an epidemiological study in the city of Newcastle upon Tyne to describe the incidence and prevalence of primary biliary cirrhosis in a stable, defined population between 1987 and 1994 using multiple case-finding methods and strict diagnostic criteria.
METHODS

Setting and Study Population
The area of study was the city of Newcastle upon Tyne in the north east of England. City boundaries were verified from the Office of National Statistics (ONS), postcode and local health authority data. Mid-year population estimates for each year were based upon the 1991 Census and ONS projections. Denominators included the whole population, the population aged у20 years and women aged у40 years. All cases were resident in Newcastle during the study period.
Study Period and Calculation of Rates
Incidence and prevalence rates, per million population at risk, were calculated for the period 1 January to 31 December each year for incidence and for 1 June each year for point prevalence, starting in 1987 and finishing in 1994. Rates for adults aged у20 years were included to aid comparison with other studies, and for women aged у40 years because primary biliary cirrhosis is a disease affecting predominately this subsection of the population.
Case-Finding Methods
Several data sources were employed to find potential cases. They were all available throughout the study period: (i) The four gastroenterologists in the city were requested to identify cases under their care. (ii) Hospital admission data on the Regional Information Systems (RIS) for all hospitals in the Newcastle District Health Authority, were searched for admission episodes using ICD-9 code 571.6, which includes all cases of biliary cirrhosis, both primary and secondary. (iii) Autoantibody screen records at the reference immunology laboratory serving all hospitals in the city during the study period were examined to identify all positive AMA results. A total of 110 900 auto-antibody screens were performed for various clinical indications over the study period. (iv) Listings from the ONS of all deaths within the study area in which ICD-9 code 571.6 appeared anywhere on the death certificate. (v) Liver pathology reports were examined for those listing a diagnosis of primary biliary cirrhosis at any of the three hospitals during the study period.
Diagnostic Criteria
Patients were considered AMA positive if they had a positive AMA titre, by immunofluorescence, to a titre of у1 in 40, at the reference immunology laboratory at the Newcastle General Hospital. The diagnosis was considered as definite in patients with all three of the following criteria, probable in those subjects with any two of the three criteria and equivocal in those with only one criteria from: (i) positive AMA; (ii) abnormal liver tests as defined by normal ranges for that hospital laboratory at time of testing (iii) diagnostic or compatible liver histology. 11 The date of diagnosis was defined as the earliest date at which the patient was found to fulfil any two of the above three criteria, in an effort to minimize bias caused by intensive case-finding.
The hospital notes were examined for demographic and clinical details. Cases not under the care of a hepatologist were traced via both hospital consultant (where appropriate) and/or the general practitioner. Confirmation of survival was obtained from the general practitioner or FHSA and all cases were flagged to the ONS and so deaths were also notified to the study group by this method. Those individuals who were still alive were offered an outpatient appointment at the primary biliary cirrhosis clinic at the Freeman Hospital, Newcastle, where they were assessed clinically and biochemically for signs and symptoms of primary biliary cirrhosis. A liver biopsy was undertaken if clinically indicated.
Ethics
Ethical approval for the study was obtained from the Joint Ethical Committee of the University of Newcastle Medical School and the Newcastle Health Authority.
RESULTS
Cases
During the study period 202 individuals were identified with potential primary biliary cirrhosis, 160 of these fulfilled at least two diagnostic inclusion criteria. All results given here pertain only to these 160 total (definite plus probable) cases. There were 99 definite cases, fulfilling all three entry criteria, the remaining 61 were classified as probable cases, fulfilling any two of the three criteria ( Table 2 ). The other 42 cases, fulfilling only one criterion, were regarded as equivocal and therefore not included in the analysis. Of these 160 total cases, 71 were truly asymptomatic at diagnosis, being identified by routine investigation of other, unconnected diseases, 40 were diagnosed during the course of investigation for symptoms of liver disease and 38 were identified and traced as a result of the case-finding exercise. The general practitioner gave permission for us to contact these latter individuals and offer them a clinic appointment at a special hepatology clinic. Clinical and biochemical data were obtained from the general practitioner of any patient not wishing to attend.
Population
The size of the whole population varied between 275 996 and 285 310. The adult population aged у20 years ranged from 208 804 to 216 570 and the female population aged у40 years varied from 64 348 to 67 012. The age distribution and sex ratios of the population remained stable throughout the study period.
Sex Ratio and Age at Diagnosis
There were 145 women and 15 men in the study amongst total cases. The female to male ratio in definite cases was 8:1 and in total cases was 9.7:1. Mean age at diagnosis in the cases incident during the study period was 66.3 years (S.D. 12.5, range 38.9-99.7) in total cases.
Incidence
There were 49 incident cases among definite cases and 96 incident cases among total cases during the 8-year (Table 3 and Figure 1 ). When the incident cases across the whole study period were considered together, it can be seen that the age-specific incidence rate is highest in the 60-69 year age group for definite cases and in the 70-79 age group for total cases ( Figure 2) . Table 3 also shows that point prevalence rates increased steadily in all populations examined over the study period and with no sign of a plateau in this trend as yet. The prevalence of definite cases for the whole population rose from 180 per million in 1987 to 240 per million in 1994 and in probable plus definite cases rose to 392 over the same period. Prevalence within adults aged у20 years and among women aged у40 years (populations most at risk of primary biliary cirrhosis) showed similar increases over the study period.
Prevalence
Mortality
There were 51 deaths amongst this case series. Primary biliary cirrhosis was the cause of death in 19 of the 52 cases, as judged by information in the case notes. In five of these, primary biliary cirrhosis was not reported on the death certificates.
DISCUSSION
The methods used in this study address many of the problems encountered in previous studies of the epidemiology of primary biliary cirrhosis. A widely accepted, valid case definition is vital and we have used the three criteria most widely accepted as necessary for a diagnosis of primary biliary cirrhosis, i.e. cholestatic liver blood tests, a positive AMA 12 and compatible liver histology. 13 These have the advantage of not depending upon clinical interpretation and are a modification of the criteria of the International Association of the Study of the Liver 14 in that we have raised the dilution of AMA titre required from 1/20 to 1/40 (hence making the test more 'rigorous'), as there is some operatordependent variation at low levels of titre.
The exclusion of all patients without a formal histological diagnosis results leads to an underestimation of the true frequency of primary biliary cirrhosis for at least two reasons. It may be difficult to justify biopsy in asymptomatic elderly subjects even with marked abnormality of LFT as well as a positive AMA, despite the high likelihood that they have primary biliary cirrhosis. Elderly or frail patients are also less likely to undergo liver biopsy if they have a classical late stage disease clinically and positive immunological and biochemical markers, making a liver biopsy unnecessary. We have therefore described results for both definite cases and total (definite plus probable) cases separately. This illustrates both the minimum rates of disease frequency arising from only the definite cases (fulfilling 
Incidence rate of primary biliary cirrhosis by age at diagnosis: Newcastle, 1987 Newcastle, -1994 the most stringent diagnostic criteria), and perhaps the more realistic rates of disease frequency adding those cases with 'probable' primary biliary cirrhosis, who, most clinical experts would agree, do have primary biliary cirrhosis. Indeed recent evidence suggests that almost all individuals who are truly AMA positive, that is both on indirect immunofluorescence and ELISA testing, have primary biliary cirrhosis, even in the face of normal liver blood tests. 7 Thus we may still be underestimating disease frequency by omitting patients with only the one criteria of a positive AMA, most of whom will ultimately develop abnormal LFT and clinical symptoms of the disease and who have diagnostic liver histology if this is sought.
Previous studies have used different methods of case finding and the use of multiple methods has not been widespread. Where multiple sources have been employed, they have often not been used for the whole study period or population, usually for logistical reasons such as lack of availability of hospital records. We have been able to use five sources of data, thus reducing the likelihood of missing cases. Perhaps the major strength of this present study is the availability of laboratory data on positive AMA tests from all autoantibody tests carried out on the study population over the study period, for whatever clinical indication: we were able to trace and follow up those not previously investigated for possible liver disease.
Our figures may still underestimate disease frequency. Inevitably we did not trace all patients and their notes from all data sources: eight sets of case notes were unobtainable from the hospitals concerned; we were unable to trace two patients identified by the immunology laboratory; a further four patients had died or refused follow up and so had no liver blood tests measured. Two of the four gastroenterologists did not have a formal case list of patients under their care with primary biliary cirrhosis and they reported patients as they were reviewed in clinic. This may have led to underreporting of cases, although the use of the immunology laboratory data and the liver histology records suggests that only cases prevalent at the start of the study could be missed. It is also possible that we have missed some AMA negative cases if no liver biopsy had been performed.
The date of diagnosis is always difficult to define in a disease with a long natural history which includes an asymptomatic phase of variable length. We have defined the date of initial diagnosis in such a way as to minimize the large changes in prevalence as a result of case-finding exercises, which has been described in previous studies. 9, 11 The tracing of all hospital notes for all patients and the use of date of first fulfilling any two case inclusion criteria appears to have overcome this problem, at least in part, as the prevalence rates show a consistent upward trend. The investigation of age at diagnosis has been restricted to cases incident within the study period; since cases prevalent at the start of the study may well have a different natural history to the incident cases, having already survived from the date of diagnosis to date of entry to the study.
The annual incidence of primary biliary cirrhosis varied widely but throughout our study was as high or higher than recent comparable studies (Table 1) , including our own. [9] [10] [11] There was no clear trend in incidence rates over the study period but the small number of cases may have masked a weak trend. Unfortunately one problem which we have encountered within this study is the small number of cases, although this is still one of the largest case series published, despite encompassing such a small geographical area.
Prevalence rates in this population have risen sharpely over the study period and are now extremely high in comparison with any other published studies (Table 1) . In 1994 the prevalence of definite cases had risen by 33% from 180 per million to 240 in 1994 and for probable plus definite cases by 73% from 226 per million in 1987 to 392 per million in 1994. These latter rates are more than double those reported from northern Sweden where they included some cases without histological confirmation. 11 Newcastle has for many years had a major academic interest in primary biliary cirrhosis. Previous studies in the north east of England reported lower rates due to fewer and less meticulous case-finding methods. 9, 15 Prevalence rates reported from Australia, 16 Canada, 17 Japan, 18 and Europe 19, 20 are in general an order of magnitude lower than those reported here and may reflect, at least in part, more intensive investigation and earlier diagnosis in this study (Table 1) . Alternatively there may be true geographical variations in the prevalence of the disease. This study is in concordance with other studies showing that the disease is more common in Northern Europe than in other parts of the world, even using apparently similar case-finding methods. 9, 15 Further study of both local and international geographical variations are needed to elucidate whether geographical differences are true or apparent, as has been suggested in the past. 21 They should use the same methods, together with an examination of the level of diagnostic activity, such as AMA testing and liver biopsy rates.
Recent evidence that earlier treatment improves prognosis, 22 together with the availability and excellent outcome of liver transplantation in these patients, 6 suggests that earlier and more complete diagnosis of cases is of increasing benefit. As such, research into geographical variation in the prevalence of primary biliary cirrhosis has service as well as academic goals, for some of the variation results from a failure to diagnose cases, and so clinicians need to be alert to the possible diagnosis.
In conclusion, we have demonstrated that primary biliary cirrhosis is far more common in this urban population than hitherto described. Nearly one in a thousand women aged у40 years have biopsy proven primary biliary cirrhosis in Newcastle and almost twice as many have probable primary biliary cirrhosis. The prevalence continues to increase. The disease incidence is also comparatively high but we have demonstrated no consistent trend over time. The rise in prevalence, therefore, is likely to result at least in part from earlier diagnosis and therefore longer survival from diagnosis. Primary biliary cirrhosis is substantially more common than is generally believed. With advances in therapeutics, and the likelihood that earlier diagnosis will benefit patients, a more rigorous approach to case-finding is recommended elsewhere.
